Unlock instant, AI-driven research and patent intelligence for your innovation.

15-oxospiramilactone derivatives, and preparation method and applications thereof

A kind of technology of meadowfoam and derivatives, applied in the field of medicine

Active Publication Date: 2015-03-18
KUNMING INST OF BOTANY - CHINESE ACAD OF SCI +2
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, there are no reports of 15-oxospirandrolactone (S-3) derivatives of the present invention in the present technology

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 15-oxospiramilactone derivatives, and preparation method and applications thereof
  • 15-oxospiramilactone derivatives, and preparation method and applications thereof
  • 15-oxospiramilactone derivatives, and preparation method and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Preparation of compounds of the present invention:

[0048] (1) The preparation routes of compounds 1-9, 25, and 26 are:

[0049]

[0050] Preparation:

[0051] Compound 1: Take the dry compound 15-oxospirandrolactone (S-3) (2.00g, 6.06mmol) from Meadowsweet pink, in N 2 Dissolve with 5ml of dry dichloromethane under protection, inject oxalyl chloride (7.28mmol, 692ul) into a long-necked low-temperature reaction bottle filled with 5ml of dry dichloromethane under nitrogen protection, and stir at -78°C for 20 minutes, then Slowly add DMSO (14.56mmol, 1032ul, in5ml DCM) solution dropwise, after 5 minutes dropwise, stir at low temperature for 30 minutes, then slowly add the dichloromethane solution of compound S-3 into the reaction flask, at -78 After stirring for 1 hour under stirring at ℃, slowly add triethylamine (14.56mmol, 2020ul) dropwise under rapid stirring. Extracted with methyl chloride, combined with dichloromethane, washed with saturated brine, dried over...

Embodiment 2

[0175] The inhibitory effect of the compound of the present invention on various tumor cell lines:

[0176] (1) Experimental method

[0177] 1. Inoculate cells: Use culture medium (DMEM or RMPI1640) containing 10% fetal bovine serum to prepare a single cell suspension, inoculate 5000-10000 cells per well into a 96-well plate with a volume of 100 μl per well, and adherent cells in advance 12 hour inoculation.

[0178] 2. Add the compound solution to be tested (fixed concentration of 40 μM for primary screening, at which concentration the compound that inhibits the growth of tumor cells near 50% is set to enter the gradient rescreening at 5 concentrations), the final volume of each well is 200 μl, and each treatment is set at 3 multiple holes.

[0179] 3. Color development: After incubating at 37 degrees Celsius for 48 hours, add 20 μl of MTT solution to each well. Continue to incubate for 4 hours, terminate the culture, discard the culture supernatant in the well, add 200 μl...

Embodiment 3

[0187] The inhibitory effect of the compounds of the present invention on the Wnt signaling pathway reporter gene Top-flash:

[0188] (1) Experimental method:

[0189] 1) Preparation of cell culture and conditioned medium:

[0190] HEK293T cells were cultured in DMEM (Invitrogen) containing 10% fetal bovine serum at 37°C, CO 2 Concentration 5%. Subculture every other day. Maintain a density of 70-80% when subcultured. The L cell line stably secreting mouse Wnt3a protein (CRL-2647 was purchased from the US ATCC cell bank) and the control strain (CRL-2648 was purchased from the US ATCC cell bank), maintained at 50ug / ml G418 and 10% fetal bovine serum DMEM, 37°C, CO 2 At a concentration of 5%. When the cells grew to about 70% density, the medium was changed (DMEM containing 10% fetal bovine serum). After four days of continuous culture, the culture medium was collected and centrifuged, and the supernatant was retained to obtain the Wnt-conditioned medium. After titer deter...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides various type derivatives of 15-oxospiramilactone, a pharmaceutical composition by taking the derivatives as an active component, a preparation method of the derivatives, and applications in preparation of antitumor drugs. During research on antitumor natural products, it is discovered that 15-oxospiramilactone possesses activities of resisting multiple tumor cell strains, and most of the derivatives are stronger than the primer 15-oxospiramilactone in activity. The above compounds are subjected to a test of inhibiting activity of Wnt signaling pathway and a test of inhibiting activity of various tumor cell strains, and it is discovered that antineoplastic activity of the above compounds is positively correlated to the activity of inhibiting Wnt signaling pathway.

Description

Technical field: [0001] The present invention belongs to the technical field of medicines, in particular, it relates to a meadowsweet diterpene 15-oxospirandrolactone (S-3) derivative, a preparation method thereof, and a pharmaceutical composition with the compound as an active ingredient. And its application in the preparation of antitumor drugs. Background technique: [0002] Despite great advances in oncology science, cancer remains by far the world's most serious public health problem. Worldwide, the number of new cancers is expected to jump from 12.7 million in 2008 to more than 20 million in 2030. Tumors have become the number one killer of human health. The incidence of "poor cancer" remains high, and "rich cancer" is also growing rapidly. my country is in the transition period from a high-incidence cancer spectrum in developing countries to a high-incidence cancer spectrum in developed countries. The reasons for the rejuvenation of cancer patients in my country inc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D311/00C07D493/10C07D493/08C07D327/10C07D295/116C07D295/205C07D333/38C07D221/22C07D491/08C07D498/08C07D498/18C07C62/38C07C51/373C07C69/18C07C69/16C07C309/66C07C303/28C07C67/293C07C69/63C07C67/28C07C67/08C07F7/18A61K31/366A61K31/5377A61K31/352A61K31/39A61K31/19A61K31/22A61K31/122A61K31/255A61K31/5375A61K31/381A61K31/439A61K31/695A61P35/00
Inventor 郝小江晏晨刘海洋何红平李林何小丽
Owner KUNMING INST OF BOTANY - CHINESE ACAD OF SCI